Minki Lee
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Inhalation and Respiratory Drug Delivery 2
- Lung Cancer Diagnosis and Treatment 2
- Lung Cancer Treatments and Mutations 2
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Hongxia Lin (3 shared papers)Dae‐Duk Kim (3 shared papers)Hwan‐Jung Roh (3 shared papers)Chang‐Koo Shim (2 shared papers)Chang Hun Lee (5 shared papers)Hyun‐Jong Cho (1 shared paper)Suk-Jae Chung (1 shared paper)Hong Li (1 shared paper)
- Journals
- Cancer Letters (1 paper)Drug Delivery (1 paper)Journal of Korean Medical Science (1 paper)International Journal of Molecular Medicine (1 paper)Biotechnology Letters (1 paper)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Minki Lee
22 papers receiving 455 citations
Peers
Comparison fields: 5 of 80
- Pharmaceutical Science 59
- Immunology 74
- Pulmonary and Respiratory Medicine 107
- Biochemistry 20
- Complementary and alternative medicine 22
Countries citing papers authored by Minki Lee
This map shows the geographic impact of Minki Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minki Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minki Lee more than expected).
Fields of papers citing papers by Minki Lee
This network shows the impact of papers produced by Minki Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minki Lee. The network helps show where Minki Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Minki Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 134 | |
| 2 | 2005 | 67 | |
| 3 | 2003 | 51 | |
| 4 | 2005 | 38 | |
| 5 | 2012 | 30 | |
| 6 | 2020 | 23 | |
| 7 | 2007 | 20 | |
| 8 | 2005 | 20 | |
| 9 | 2016 | 15 | |
| 10 | 2021 | 9 | |
| 11 | 2011 | 9 | |
| 12 | 2017 | 8 | |
| 13 | 2004 | 8 | |
| 14 | 2007 | 8 | |
| 15 | 2021 | 7 | |
| 16 | 2012 | 4 | |
| 17 | 2012 | 3 | |
| 18 | Significance of Galectin-3 Expression in Pulmonary Non-Small Cell Carcinoma | 2006 | 2 |
| 19 | 2024 | 2 | |
| 20 | 2015 | 2 |
About Minki Lee
Minki Lee is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Molecular Biology, Oncology and Biochemistry, having authored 23 papers that have together received 463 indexed citations. Recurring topics across this work include Phytochemicals and Antioxidant Activities (3 papers), Immunotherapy and Immune Responses (3 papers), Inhalation and Respiratory Drug Delivery (2 papers), RNA Interference and Gene Delivery (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Lung Cancer Research Studies (2 papers), Peptidase Inhibition and Analysis (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Pharmaceutical Science (59 citations), Immunology (74 citations), Pulmonary and Respiratory Medicine (107 citations), Biochemistry (20 citations) and Complementary and alternative medicine (22 citations). Minki Lee has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Hongxia Lin, Dae‐Duk Kim, Hwan‐Jung Roh, Chang‐Koo Shim, Chang Hun Lee, Hyun‐Jong Cho, Suk-Jae Chung, Hong Li, Shengjie Bian and Jin‐Wook Yoo. Their work appears in journals such as Cancer Letters, Drug Delivery, Journal of Korean Medical Science, International Journal of Molecular Medicine and Biotechnology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.